[ad_1]
DLA Piper is offering authorized counsel to Calliditas Therapeutics AB (Calliditas), a biopharmaceutical firm based mostly in Sweden, in relation to the latest tender supply made by Asahi Kasei Company (Asahi), a conglomerate from Japan. Asahi has provided to amass all of Calliditas’ excellent shares and American Depositary Shares (ADSs) for a complete of US$1.1 billion. Calliditas’ shares are listed on Nasdaq Stockholm, whereas its ADSs are listed on the Nasdaq World Choose Market.
Calliditas is a specialty biopharmaceutical firm that has already commercialized its first product, TARPEYO®, within the US for the therapy of sufferers with immunoglobulin A nephropathy (IgAN), a renal illness. The corporate has licensed this product to companions within the EU, Japan, China, and Singapore, the place it’s presently being developed and marketed.
Calliditas can also be engaged on the event of setanaxib, a NOX inhibitor, for the therapy of varied illnesses, together with head and neck most cancers, alport syndrome, major biliary cholangitis, and idiopathic pulmonary fibrosis. Asahi expects that this enterprise mixture will assist speed up its transformation into a world specialty pharmaceutical enterprise.
Josh Kaufman (NY/Miami), Co-Chair of DLA’s Capital Markets and Public Firms Advisory Follow, is main the deal workforce alongside companions Sanjay Shirodkar (DC) and Jonathan Klein (New York). Kaufman highlighted DLA Piper’s cross-border capabilities, intensive expertise within the biopharmaceutical trade, and robust international M&A observe as explanation why Calliditas selected to work with them.
“Firms flip to us for our cross-border capabilities. We’re happy to be advising Calliditas based mostly on our deep biopharmaceutical trade expertise, our main international M&A observe and our capability to seamlessly execute throughout three continents,” stated Josh Kaufman (NY/Miami), Co-Chair of DLA’s Capital Markets and Public Firms Advisory Follow
The DLA Piper workforce additionally contains companions Rita Patel and Keith Ranta (each in Washington, DC), Jamie Knox and Paolo Morante (each in New York), Semin O (Frankfurt), and Ting Xiao (Shanghai), in addition to associates Jenna Fontenot (Miami), Alex Carlson (Los Angeles), and Myriem Bennani (Chicago).
Revealed by: www.lawyer-monthly.com
[ad_2]